Holen Sie sich die Stockscreener-App
100.69
1.52%
1.51
Handel nachbörslich:
100.99
0.30
+0.30%
Überblick
Nachrichten
Preisverlauf
Optionskette
Financials
Forum
Prognose
Aktiensplit
Dividendenhistorie
Schlusskurs vom Vortag:
$99.18
Offen:
$99.27
24-Stunden-Volumen:
14.23M
Relative Volume:
1.05
Marktkapitalisierung:
$249.91B
Einnahmen:
$63.90B
Nettoeinkommen (Verlust:
$19.05B
KGV:
13.32
EPS:
7.5596
Netto-Cashflow:
$13.05B
1W Leistung:
+1.70%
1M Leistung:
+4.42%
6M Leistung:
+26.99%
1J Leistung:
+2.39%
1-Tages-Spanne:
$98.86
$101.37
1-Wochen-Bereich:
$96.79
$101.37
52-Wochen-Spanne:
$73.31
$105.84
Merck Co Inc Stock (MRK) Company Profile
Firmenname
Merck Co Inc
Sektor
Telefon
908-740-4000
Adresse
126 EAST LINCOLN AVENUE, RAHWAY, NJ
Vergleichen Sie MRK mit anderen Aktien
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
MRK
Merck Co Inc
|
100.69 | 246.17B | 63.90B | 19.05B | 13.05B | 7.5596 |
|
LLY
Lilly Eli Co
|
1,056.88 | 932.42B | 59.42B | 18.41B | 6.44B | 20.22 |
|
JNJ
Johnson Johnson
|
208.31 | 506.75B | 92.15B | 25.12B | 20.46B | 10.36 |
|
ABBV
Abbvie Inc
|
222.82 | 396.44B | 59.64B | 2.36B | 19.68B | 1.3253 |
|
NVS
Novartis Ag Adr
|
135.27 | 259.09B | 54.45B | 14.42B | 17.15B | 7.333 |
Merck Co Inc Stock (MRK) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung |
|---|---|---|---|
| 2025-11-24 | Hochstufung | Wells Fargo | Equal Weight → Overweight |
| 2025-11-13 | Eingeleitet | Scotiabank | Sector Outperform |
| 2025-10-13 | Fortgesetzt | Citigroup | Neutral |
| 2025-09-17 | Herabstufung | Berenberg | Buy → Hold |
| 2025-05-14 | Herabstufung | Citigroup | Buy → Neutral |
| 2025-04-22 | Eingeleitet | Cantor Fitzgerald | Neutral |
| 2025-02-18 | Herabstufung | Deutsche Bank | Buy → Hold |
| 2025-02-10 | Herabstufung | TD Cowen | Buy → Hold |
| 2025-01-08 | Herabstufung | Truist | Buy → Hold |
| 2024-12-20 | Herabstufung | BMO Capital Markets | Outperform → Market Perform |
| 2024-12-10 | Fortgesetzt | BofA Securities | Buy |
| 2024-12-04 | Hochstufung | HSBC Securities | Hold → Buy |
| 2024-11-15 | Eingeleitet | Wolfe Research | Peer Perform |
| 2024-11-11 | Herabstufung | Daiwa Securities | Buy → Neutral |
| 2024-10-17 | Eingeleitet | Bernstein | Mkt Perform |
| 2024-03-11 | Herabstufung | Societe Generale | Hold → Sell |
| 2024-01-04 | Hochstufung | TD Cowen | Market Perform → Outperform |
| 2023-11-09 | Eingeleitet | Deutsche Bank | Buy |
| 2023-10-27 | Hochstufung | BMO Capital Markets | Market Perform → Outperform |
| 2023-10-20 | Hochstufung | UBS | Neutral → Buy |
| 2023-07-14 | Eingeleitet | HSBC Securities | Hold |
| 2023-04-13 | Hochstufung | Citigroup | Neutral → Buy |
| 2023-03-28 | Herabstufung | Societe Generale | Buy → Hold |
| 2023-03-13 | Herabstufung | Wells Fargo | Overweight → Equal Weight |
| 2023-03-06 | Eingeleitet | Jefferies | Buy |
| 2023-02-22 | Hochstufung | Wolfe Research | Peer Perform → Outperform |
| 2023-01-04 | Hochstufung | BofA Securities | Neutral → Buy |
| 2022-11-18 | Eingeleitet | Credit Suisse | Outperform |
| 2022-10-10 | Hochstufung | Guggenheim | Neutral → Buy |
| 2022-09-14 | Hochstufung | Berenberg | Hold → Buy |
| 2022-07-06 | Hochstufung | Daiwa Securities | Neutral → Buy |
| 2022-06-06 | Fortgesetzt | SVB Leerink | Outperform |
| 2022-04-06 | Fortgesetzt | Morgan Stanley | Equal-Weight |
| 2021-12-17 | Eingeleitet | Goldman | Buy |
| 2021-12-16 | Eingeleitet | Daiwa Securities | Neutral |
| 2021-12-13 | Herabstufung | UBS | Buy → Neutral |
| 2021-12-09 | Eingeleitet | Wells Fargo | Overweight |
| 2021-12-07 | Herabstufung | Guggenheim | Buy → Neutral |
| 2021-11-29 | Herabstufung | Citigroup | Buy → Neutral |
| 2021-11-19 | Eingeleitet | BMO Capital Markets | Market Perform |
| 2021-11-01 | Hochstufung | Argus | Hold → Buy |
| 2021-09-07 | Herabstufung | Morgan Stanley | Overweight → Equal-Weight |
| 2021-07-27 | Fortgesetzt | Truist | Buy |
| 2021-05-20 | Herabstufung | Argus | Buy → Hold |
| 2021-04-07 | Fortgesetzt | RBC Capital Mkts | Sector Perform |
| 2020-11-10 | Fortgesetzt | Bernstein | Outperform |
| 2020-09-29 | Eingeleitet | Berenberg | Hold |
| 2020-08-03 | Hochstufung | Goldman | Neutral → Buy |
| 2020-06-12 | Herabstufung | Wolfe Research | Outperform → Peer Perform |
| 2020-02-27 | Eingeleitet | Barclays | Overweight |
| 2020-01-07 | Eingeleitet | RBC Capital Mkts | Sector Perform |
| 2019-10-17 | Fortgesetzt | BofA/Merrill | Neutral |
| 2019-08-16 | Eingeleitet | SVB Leerink | Outperform |
| 2019-07-03 | Eingeleitet | Mizuho | Buy |
| 2019-05-28 | Eingeleitet | Goldman | Neutral |
| 2019-05-13 | Hochstufung | Atlantic Equities | Neutral → Overweight |
| 2018-10-16 | Bestätigt | Citigroup | Buy |
| 2018-10-09 | Fortgesetzt | Guggenheim | Buy |
| 2018-04-23 | Hochstufung | Goldman | Neutral → Buy |
| 2018-04-17 | Hochstufung | Morgan Stanley | Equal-Weight → Overweight |
| 2018-04-05 | Hochstufung | Barclays | Equal Weight → Overweight |
| 2018-03-12 | Hochstufung | Leerink Partners | Mkt Perform → Outperform |
| 2018-02-14 | Bestätigt | Leerink Partners | Mkt Perform |
| 2018-02-07 | Bestätigt | Morgan Stanley | Equal-Weight |
| 2018-01-16 | Hochstufung | SunTrust | Hold → Buy |
Alle ansehen
Merck Co Inc Aktie (MRK) Neueste Nachrichten
Merck & Co., Inc. (NYSE:MRK) Stock Price Up 1.6% Following Analyst Upgrade - MarketBeat
Merck Cholesterol, Cancer Drugs May Enter FDA Fast-Track Program: Report - Benzinga
Merck & Co., Inc. (NYSE:MRK) Upgraded at BMO Capital Markets - MarketBeat
FDA Mulls National Priority Vouchers for Two Potential Merck Blockbusters: Report - BioSpace
Here Are Thursday’s Top Wall Street Analyst Research Calls: Digital Realty, GE Vernova, Micron Technology, Merck & Co., Rivian, United Airlines, and More - 24/7 Wall St.
27,329 Shares in Merck & Co., Inc. $MRK Purchased by Montecito Bank & Trust - MarketBeat
Thurston Springer Miller Herd & Titak Inc. Lowers Stock Holdings in Merck & Co., Inc. $MRK - MarketBeat
BMO Capital Upgrades Merck & Co. to Outperform From Market Perform, Adjusts PT to $130 From $82 - marketscreener.com
Czech National Bank Boosts Stake in Merck & Co., Inc. $MRK - MarketBeat
Merck & Co., Inc. (NYSE:MRK) Shares Acquired Rep. Gilbert Ray Cisneros, Jr. - MarketBeat
Merck (MRK) Stock After Hours: FDA Fast‑Track Vouchers, Keytruda‑Padcev Trial Win, and What to Watch Before the Dec. 18 Market Open - ts2.tech
Merck & Co., Inc. (MRK) sees mixed analyst views as Europe advances WINREVAIR review - MSN
Merck & Co., Inc. (MRK) Sees Mixed Analyst Views as Europe Advances WINREVAIR Review - Insider Monkey
Merck cholesterol, cancer therapies to receive national priority vouchersreport - Seeking Alpha
Exclusive-US FDA taps Merck drugs with blockbuster sales potential for national priority vouchers - Yahoo Finance
Why Merck Co Inc Common Stock 6MK0 stock stays undervaluedQuarterly Risk Review & Risk Controlled Stock Alerts - moha.gov.vn
BofA Turns More Positive on Merck (MRK) Pipeline - Finviz
BTK Inhibitors Clinical Trial Pipeline Accelerates as 30+ Pharma Companies Rigorously Develop Drugs for Market Entry | DelveInsight - GlobeNewswire Inc.
Merck's Keytruda-Padcev Combo Boosts Survival In Pivotal Bladder Cancer Trial - Benzinga
Pfizer, Merck Are Boring Again: 2026 Investors Are Circling BackMerck & Co (NYSE:MRK), Pfizer (NYSE:PFE) - Benzinga
Union Bancaire Privee UBP SA Has $34.88 Million Stake in Merck & Co., Inc. $MRK - MarketBeat
Merck Animal Health Announces Availability of Circumvent® CL, a Ready-to-use Vaccine Protecting Pigs Against Porcine Circovirus Types 2a and 2d and Lawsonia intracellularis - American Ag Network
Quintet Private Bank Europe S.A. Increases Holdings in Merck & Co., Inc. $MRK - MarketBeat
Insight Wealth Strategies LLC Purchases New Position in Merck & Co., Inc. $MRK - MarketBeat
Assenagon Asset Management S.A. Buys 3,618,532 Shares of Merck & Co., Inc. $MRK - MarketBeat
Merck & Co., Inc. (NYSE:MRK) Shares Down 2%Here's Why - MarketBeat
Merck (MRK) Price Target Lifted at Morgan Stanley as Biopharma Outlook Improves - Insider Monkey
Merck (MRK) Stock News Today: Why Shares Slid on Dec. 16, 2025 as Analysts Reassess Keytruda, Winrevair, and Merck’s Post‑Patent Strategy - ts2.tech
Trust Co of the South Sells 14,016 Shares of Merck & Co., Inc. $MRK - MarketBeat
Merck & Co., Inc. $MRK Holdings Lowered by Westwood Holdings Group Inc. - MarketBeat
Red Spruce Capital LLC Reduces Stock Holdings in Merck & Co., Inc. $MRK - MarketBeat
Merck & Co., Inc. $MRK Shares Bought by Nilsine Partners LLC - MarketBeat
Iowa State Bank Cuts Stock Holdings in Merck & Co., Inc. $MRK - MarketBeat
Shorepoint Capital Partners LLC Invests $4.17 Million in Merck & Co., Inc. $MRK - MarketBeat
Osaic Holdings Inc. Grows Position in Merck & Co., Inc. $MRK - MarketBeat
Cardinal Capital Management Inc. Buys 24,204 Shares of Merck & Co., Inc. $MRK - MarketBeat
GAMMA Investing LLC Has $5.78 Million Stake in Merck & Co., Inc. $MRK - MarketBeat
Merck (MRK) Stock After Hours Today (Dec. 15, 2025): What’s Moving Shares and What to Watch Before Tuesday’s Open - ts2.tech
Merck Stock (MRK) News Today: BofA Raises Target to $120 as Winrevair Expansion and Dividend Date Spotlight 2026 Outlook - ts2.tech
Merck & Co's Options: A Look at What the Big Money is Thinking - Benzinga
Valeo Financial Advisors LLC Reduces Stock Position in Merck & Co., Inc. $MRK - MarketBeat
V. M. Manning & CO. Inc. Invests $1.17 Million in Merck & Co., Inc. $MRK - MarketBeat
Merck & Co., Inc. (NYSE:MRK) Stock Price Expected to Rise, Bank of America Analyst Says - MarketBeat
Neville Rodie & Shaw Inc. Trims Stake in Merck & Co., Inc. $MRK - MarketBeat
Merck & Co., Inc. $MRK Shares Sold by Texas Permanent School Fund Corp - MarketBeat
Stance Capital LLC Invests $1.26 Million in Merck & Co., Inc. $MRK - MarketBeat
Merck & Co., Inc. $MRK Shares Sold by Kestra Investment Management LLC - MarketBeat
Rep. Julie Johnson Sells Off Shares of Merck & Co., Inc. (NYSE:MRK) - MarketBeat
Cullen Capital Management LLC Grows Holdings in Merck & Co., Inc. $MRK - MarketBeat
Merck & Co., Inc. $MRK Shares Bought by Corient Private Wealth LLC - MarketBeat
China Universal Asset Management Co. Ltd. Cuts Position in Merck & Co., Inc. $MRK - MarketBeat
Finanzdaten der Merck Co Inc-Aktie (MRK)
Umsatz
Nettogewinn
Free Cashflow
ENV
0.18%
0.33%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):